Promoting and facilitating strategies to improve cardiovascular health worldwide

Meeting Highlights

From the 26th Annual Scientific Meeting of the ISCP – Singapore

 

 

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar

 

 

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

VIDEO: AHA includes ‘exciting’ early research on HF treatments

Posted on November 30, 2021

In this video, Nancy K. Sweitzer, MD, PhD, director of the University of Arizona Sarver Heart Center and professor of medicine and... more

Intensive BP reduction may not prevent adverse cognitive outcomes

Posted on November 30, 2021

Intensive blood pressure reduction did not appear to prevent cognitive decline and dementia, according to results of a systematic review and meta-analysis... more

Cardiopulmonary exercise testing valuable to assess unexplained dyspnea post-COVID-19

Posted on November 30, 2021

In a small study, cardiopulmonary exercise testing identified significant abnormalities, including dysfunctional breathing, resting hypocapnia and chronic fatigue syndrome, associated with post-acute... more

EHR data reveal ‘red flag’ comorbidities years before cardiac amyloidosis diagnosis

Posted on November 30, 2021

Common “red flag” comorbid conditions stored in the electronic health record often preceded the diagnosis of cardiac amyloidosis by years, according to... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •  Jack Tan

    President

      Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Thomas Kahan

    President Elect

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •  Doreen Tan

    Co Treasurer

      Doreen Su-Yin Tan is Associate Professor, Clinical & Pharmacy Practice, at the National University of Singapore. Affiliations (more…) more

  •  Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more